CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

Medtronic's diabetes care unit has grown faster than the rest of its business in recent years. Over the past few years, ...

Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months ...

The global AI in Remote Patient Monitoring Market valued at US$1551.8 million in 2023, stood at US$1,967.7 million in 2024 ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Global Insulin Pumps Market ...

Medtronic plc revealed plans to spin off its underperforming diabetes unit as a separate public company during its fourth quarter 2025 earnings call on May 21. The company expects to complete the ...

Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, ...

the company is also seeking approval of an all-in-one diabetes management system that would pair a Medtronic insulin pump and dosing algorithm with Abbott’s continuous glucose monitor technology ...

Medtronic announced plans to spin off its once-strained but now-growing diabetes business into an independent company, allowing the medtech giant to focus on high-growth markets such as pulsed field ...

On the other hand, CGMs offer continuous, real-time monitoring, allowing users to track trends ... Like other CGMs, it uses interstitial fluids to measure blood glucose. Unlike Dexcom and Medtronic, ...